Join
Live feed
·
INSIDERFilingvia Quantisnow
Aquestive Therapeutics Inc. logo

Chief Commercial Officer Korczynski Sherry was granted 75,000 shares and sold $65,687 worth of shares (15,741 units at $4.17), increasing direct ownership by 33% to 241,117 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AQST (Aquestive Therapeutics Inc.) and more on Quantisnow.